Industries > Pharma > Brazilian Pharmaceutical Market Outlook 2017-2027

Brazilian Pharmaceutical Market Outlook 2017-2027

Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies

PUBLISHED: 18 August 2017
PAGES: 181
PRODUCT CODE: PHA0226

Clear
WOOCS 2.2.1

The Brazilian Pharmaceutical market was valued at $26.40bn in 2016. Visiongain forecasts this market to increase at a CAGR of 7.6% in the first half of the forecast period. Originator drugs held the largest market share in 2016, this trend however will change in the second half of the forecast period where we predicted that Generic drugs will take over the lead.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 181-page report you will receive 107 charts – all unavailable elsewhere.

The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Brazilian Pharmaceutical Market forecasts from 2017-2027

• Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment:
• Originator Drugs
• Generic Drugs
• OTC

Brazilian Pharmaceutical Market forecasts from 2017-2027, by therapeutic area:
• CNS
• Cardiovascular
• Gastrointestinal/Metabolic
• Oncology
• Infectious Disease

Brazilian Pharmaceutical Market Outlook 2017-2027

• Leading Domestic Companies in the Brazilian Pharmaceutical Market:
• EMS
• Hypermarcas
• Medley
• Eurofarma
• Aché
• Cristalia
• Teuto
• Libbs
• Biolab
• União Química

• Leading Multinational Companies in the Brazilian Pharmaceutical Market:
• Novartis
• Sanofi
• Roche
• Merck & Co.
• Pfizer
• Takeda
• Bayer
• GlaxoSmithKline
• Boehringer Ingelheim
• Astra Zeneca

SWOT and STEP Analysis of the Brazilian Pharmaceutical market

• This report also discusses:
• The Brazilian healthcare environment, covering important institutional bodies and agencies, surveying the regulatory system, analyzing the balance between public and private healthcare provision and looking at the wholesale and distribution landscape
Regional variations within Brazil, with profiles of each region and an analysis of their healthcare challenges and opportunities
Brazilian Biologics Market, which includes qualitative and quantitative analysis.

Visiongain’s study is intended for anyone requiring commercial analyses for the Brazilian Pharmaceutical market and the leading companies competing in that country. You find data, trends and predictions.

Buy our report today Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories